Company Filing History:
Years Active: 2024
Title: Innovations in Cancer Treatment by Nada Lallous
Introduction
Nada Lallous is an accomplished inventor based in Vancouver, Canada. She has made significant contributions to the field of cancer therapeutics through her innovative research and development of Myc-Max inhibitor compounds. Her work aims to provide new treatment options for various types of cancer, showcasing her dedication to improving patient outcomes.
Latest Patents
Nada Lallous holds a patent for her invention titled "Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith." This patent includes Myc-Max inhibitory compounds that have the potential to treat several cancers, including prostate cancer, breast cancer, colon cancer, cervical cancer, small-cell lung carcinomas, neuroblastomas, osteosarcomas, glioblastomas, melanoma, and myeloid leukaemia. She has 1 patent that reflects her innovative approach to cancer treatment.
Career Highlights
Nada Lallous is affiliated with the University of British Columbia, where she conducts her research. Her work is characterized by a strong focus on developing therapeutic strategies that target specific cancer pathways. This focus has positioned her as a key figure in the ongoing fight against cancer.
Collaborations
Nada collaborates with esteemed colleagues, including Artem Tcherkassov and Paul S Rennie. These partnerships enhance her research efforts and contribute to the advancement of cancer therapeutics.
Conclusion
Nada Lallous is a pioneering inventor whose work in Myc-Max inhibitor compounds represents a significant advancement in cancer treatment. Her dedication to research and collaboration continues to inspire progress in the field of oncology.